Definitely fingers crossed!
I trust your assessment for the timing of approvals, and also doubt we get anything on that front this year — we’re only ten or so weeks from year end.
But between the journal article with the possible announcement of a partnership and an uplist, there might be enough drivers to get this over $2. I’m sure there will be plenty of resistance at that level, but if they can get a listing that will provide the access for institutional investors, that will be a game changer.
I know, it’s a lot to ask. But I’m a big believer — and delusional enough — that the journal article is the trigger for everything else. I’ve said before, the JA is likely a requirement by partners that want a credible story they can tell The Street.
Market Data 
Markets 
